To support this idea, in this study, we evaluate whether s-IgE/t-IgE ratio can predict clinical improvement in monosensitized patients to house dust mite treated with immunotherapy and found that s-IgE/t-IgE ratio would be useful to predict the clinical response to SIT especially in patients with allergic rhinitis. The gene discussed is IGHE; the disease is allergic rhinitis.